Pantoprazole and omeprazole as components of first line triple therapy in patients with helicobacter pylori infections receiving clarithromycin and amoxicillin.

Trial Profile

Pantoprazole and omeprazole as components of first line triple therapy in patients with helicobacter pylori infections receiving clarithromycin and amoxicillin.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2010

At a glance

  • Drugs Pantoprazole (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole; Omeprazole
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jul 2010 New trial record
    • 01 May 2010 Interim results in 232 patients were reported at the Digestive Disease Week 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top